サトウ アツシ
佐藤 淳 所属 応用生物学部 応用生物学科 職種 教授 |
|
言語種別 | 英語 |
発行・発表の年月 | 2021/11 |
形態種別 | 学術論文 |
査読 | 査読あり |
標題 | BST1 regulates nicotinamide riboside metabolismvia its glycohydrolase and base-exchange activities |
執筆形態 | 共著 |
掲載誌名 | Nature Communications |
掲載区分 | 国外 |
出版社・発行元 | Nature |
巻・号・頁 | 12,pp.6767 |
著者・共著者 | Keisuke Yaku, Sailesh Palikhe, Hironori Izumi, Tomoyuki Yoshida, Keisuke Hikosaka, Faisal Hayat, Mariam
Karim, Tooba Iqbal, Yasuhito Nitta, Atsushi Sato, Marie E Migaud, Katsuhiko Ishihara, Hisashi Mori, Takashi Nakagawa |
概要 | Nicotinamide riboside (NR) is one of the orally bioavailable NAD+ precursors and has been demonstrated to exhibit beneficial effects against aging and aging-associated diseases. However, the metabolic pathway of NR in vivo is not yet fully understood. Here, we demonstrate that orally administered NR increases NAD+ level via two different pathways. In the early phase, NR was directly absorbed and contributed to NAD+ generation through the NR salvage pathway, while in the late phase, NR was hydrolyzed to nicotinamide (NAM) by bone marrow stromal cell antigen 1 (BST1), and was further metabolized by the gut microbiota to nicotinic acid, contributing to generate NAD+ through the Preiss-Handler pathway. Furthermore, we report BST1 has a base-exchange activity against both NR and nicotinic acid riboside (NAR) to generate NAR and NR, respectively, connecting amidated and deamidated pathways. Thus, we conclude that BST1 plays a dual role as glycohydrolase and base-exchange enzyme during oral NR supplementation. |
外部リンクURL | https://www.nature.com/articles/s41467-021-27080-3 |